Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial - Franz, D N; Belousova, E; Sparagana, S (Lancet, 2013)
(9861):